the newest generation of drug eluting stents and beyond的八卦，YOUTUBE和 Yahoo名人娛樂都在討論：

#11. Drug-eluting stent technology: progress beyond the polymer

Biodegradable polymers have been embraced as a promising development to overcome this limitation. However, refinements of new-generation DES ...

#12. New drug-eluting stents: technological refinement continues

Beyond the increased rate of stent thrombosis, the first-generation of this type of stents had additional limitations: they were stainless-steel platforms with ...

#13. Stent Thrombosis in Randomized Clinical Trials of Drug ...

The incidence of stent thrombosis did not differ significantly between patients with drug-eluting stents and those with bare-metal stents in randomized clinical ...

#14. Design, manufacture and initial tests of a drug-eluting ...

A drug-eluting coronary stent is being developed at the National Institute of ... The newest generation of drug-eluting stents and beyond.

#15. A new generation of drug-eluting stents - Cleveland Clinic ...

Drug -eluting stents (DES) are increasingly being used as a less invasive alternative to coronary artery bypass grafting. Early generation DES ...

#16. Superiority of biodegradable polymer sirolimus-eluting stents ...

European guidelines first recommended the use of new-generation drug-eluting stents rather than bare-metal stents in STEMI.

#17. Third-generation zotarolimus-eluting and everolimus ... - ZGT

generation drug -eluting stents in a broad population of all-comer patients. ... No definite stent thrombosis occurred beyond 3 months.

#18. generation drug-eluting stents compared to bare metal stents

由 C Varenhorst 著作 · 2018 · 被引用 24 次 — Stent thrombosis rates the first year and beyond with new- and old- ... Objectives Old-generation drug-eluting coronary stents (o-DES) have ...

#19. Bare metal stents, durable polymer drug eluting ... - The BMJ

Considerably lower risk of stent thrombosis and restenosis in “new generation” drug-eluting stents: a report from the nation wide complete ...

#20. The third generation of drug-eluting stents - Revista ...

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled ...

#21. Durable Versus Biodegradable Polymer Drug-Eluting Stents

eration of coronary drug-eluting stents (DES), ... file, new DES devices were developed. ... beyond 1 year, as is the case with the first-generation.

#22. Understanding and managing in-stent restenosis: a review of ...

The advent of drug-eluting stent (DES), especially 2nd generation, ... On the other hand, the presence of metallic struts promotes a new mechanism called ...

#23. The Newest Generation of Drug-eluting Stents and Beyond ...

There has been a great evolution in the development of coronary stents in order to avoid both ... The Newest Generation of Drug-eluting Stents and Beyond.

#24. A Review of the Ultrathin Orsiro Biodegradable Polymer Drug ...

In recent years, there has been a focus on a new generation of drug-eluting stents (DES), such as biodegradable polymer DES (BP-DES).

#25. Association of Second-Generation Drug-Eluting Stent Length ...

Association of Second-Generation Drug-Eluting Stent Length With 2-Year Adverse Clinical Outcomes Among Japanese Patients With Ischemic Heart ...

#26. Drug-eluting Stents Market Predicted to Rise at a Lucrative ...

Drug-eluting Stents Market: Decoding the Newest Generation of Drug-eluting Stents, and Beyond. As the healthcare industry reforms to convert ...

#27. Pathologic Etiologies of Late and Very Late Stent Thrombosis ...

Drug -eluting stents (DES) have dramatically reduced restenosis rates and have ... with first-generation DES (sirolimus-(SES) and paclitaxel-eluting stents ...

#28. Durably Biocompatible? New-Generation DES Show Superior ...

Owing to their high antirestenotic efficacy and safety, drug-eluting stents (DES) have become a cornerstone of percutaneous treatment ...

#29. Personalized Vs. Standard Duration of Dual Antiplatelet ...

New -generation metallic drug-eluting stents represent the standard of care among patients undergoing percutaneous coronary intervention (PCI).

#30. Second - versus First-generation Drug-eluting Stents

BMS and first-generation DES, such as sirolimus-eluting (Cypher ® ) and paclitaxel-eluting stents (Taxus ® ), have further improved the results of ...

#31. First-generation drug-eluting stents ... and beyond - Document ...

This issue of Drug Safety includes an authoritative and detailed review of the efficacy and safety performance of first-generation drug-eluting stents, ...

#32. Drug Eluting Stent Compounds Article - StatPearls

Drug-eluting stents (DES) are vascular prostheses used by interventional ... The Newest Generation of Drug-eluting Stents and Beyond.

#33. Drug-Eluting Stents - US Pharmacist

First-generation DES include sirolimus-eluting stents (SES; ... a reduction in cardiovascular (CV) events. 14,15 The newest member of the PES ...

#34. Biotronik Prepares For Next Era Of Drug-Eluting Stents

“These results suggest that among second-generation drug-eluting stents and beyond, the type of drug-eluting stent used is most influential ...

#35. Second-generation drug-eluting stents and beyond

Second-generation drug-eluting stents and beyond ... The latest technical development is a bioresorbable vascular scaffold that aims at ...

#36. Stent thrombosis rates the first year and beyond with new- and old ...

Objectives: Old-generation drug-eluting coronary stents (o-DES) have despite being safe and effective been associated with an increased propensity of late stent ...

#37. Risk of Stent Thrombosis Among Bare-Metal Stents ... - CORE

bare-metal stents (BMS), first-generation drug-eluting stents (G1-DES), and second-generation ... increased risk of stent thrombosis events beyond 1 year.

#38. The benefits of drug-eluting stents in the treatment of coronary ...

Furthermore, it is yet unclear whether the new endothelium that covers ... Emergence of the first-generation drug-eluting stent devices as a ...

#39. Resolute Onyx DES - Coronary Stents - Medtronic

Resolute Onyx™ is a drug-eluting stent (DES) that's different by design, ... Onyx ONE Global Trial — results published in The New England Journal of ...

#40. NEW GENERATIONS OF DRUG-ELUTING STENTS - EMJ

This review focuses on describing new generations of drug-eluting stents (DES) based on the use of novel stent platforms, coatings, and carrier systems, ...

#41. Coronary Drug-Eluting Stent - Medscape Reference

Drug -eluting stents (DES) are coated with an antiproliferative drug, which allows drug elution into the coronary wall for weeks after stent ...

#42. Stent Thrombosis - The Cardiology Advisor

Events beyond 6 months are exceedingly rare. With first generation drug-eluting stents, early events occur at the same low frequency as bare-metal stents.

#43. XIENCE Drug-Eluting Stents - Abbott cardiovascular

Implanted in over 15 million patients and studied in 120+ clinical trials,* XIENCE™ Stent provides consistent long-term safety data beyond 10 years.

#44. Comparison of Two Third-Generation Drug-Eluting Stents ...

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest ...

#45. Drug-eluting Stents Market: Decoding the Newest Generation of ...

As per Transparency Market Research, “The global drug-eluting stents market will grow at a compound annual growth rate of about 5% from 2019 to 2027, which will ...

#46. Drug eluting stents: Current status and new developments

Com- pared to BMS, the first generation DES (sirolimus and paclitaxel eluting stents) effectively reduced the rate of stent restenosis;.

#47. Drug-eluting Stents: Are They Safe? - YouTube

Drug -eluting stents are metal mesh tubes coated with medication that keep artries from re-blocking after angioplasty.

#48. BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR ...

New Category of Drug-Eluting Stent Approved For U.S. Patients. ... “The SYNERGY Stent is a next generation therapy designed to improve patient outcomes and ...

#49. DRUG-ELUTING STENTS: STATE-OF-THE-ART - FI-Admin

4-7 To minimize inadequate endothelial responses to first-generation PS and to overcome the technology of their predecessors, new devices have been developed ...

#50. Sirolimus Eluting Coronary Stent System with a ... - SlidePlayer

This is the first project where a proven technology of a drug Eluting Stent is ... YUKON Choice PC is a third generation Sirolimus eluting Stent System that ...

#51. Comparison of Clinical Outcomes Between Second-and First ...

Background and Objectives: The second-generation drug-eluting stents have been used to treat chronic total occlusion lesion.

#52. Abluminus DES: Sirolimus Drug Eluting Coronary Stent

Sirolimus Drug Eluting Coronary Stent addresses unmet clinical needs especially in Diabetes Mellitus and Acute Myocardial infarction patients.

#53. Five-year outcome of a randomised trial comparing second ...

... the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent ... with new-generation durable polymer drug-eluting stents (DP-DES), no sign.

#54. Platelets in Thrombotic and Non-Thrombotic Disorders: ...

However, in patients with drug-eluting stents, evidence supports the persistence of risk of stent thrombosis even beyond the first year (Mauri et al. 2007).

#55. The Next Generation of DES | DAIC - Diagnostic and ...

This new generation of drug-eluting stents (DES) promises increased deliverability and radial strength in the platform. New polymers will minimize the ...

#56. Drug Delivery Devices and Therapeutic Systems

Subsequently, a second generation able to patients implanted with ... the first drug(Medtronic) were the first of the second- eluting bioresorbable stent ...

#57. Dual Antiplatelet Therapy for Coronary and Peripheral ...

Clinical end points in coronary stent trials: a case for standardized definitions ... clopidogrel after predominantly second-generation drug-eluting stents.

#58. Textbook of Interventional Cardiology: Global Perspective

... in the development of drug-eluting stents (DES) with antiproliferative agents to reduce/mitigate restenosis. First-generation DES, sirolimus-eluting and ...

#59. Cardiovascular Catheterization and Intervention: A Textbook ...

A Textbook of Coronary, Peripheral, and Structural Heart Disease, ... Newer-generation zotarolimus-eluting stents (ZES, Medtronic Corporation, Minneapolis, ...

#60. SAGE Sourcebook of Modern Biomedical Devices: Business ...

The global drug delivery market earned $426.9 billion in 2005,10 a ... efficacy for conventional therapies and procedures (drug-eluting stents, liposomes).

#61. Key Trials of the Decade, An Issue of Interventional ...

Predictors and variability of drug-eluting vs bare-metal stent selection in ... and efficacy of the next generation resolute Onyx zotarolimus-eluting stent: ...

#62. Lysosomal Storage Disease Treatment Market Size, Share ...

Report Ocean presents a new report on Lysosomal Storage Disease ... of novel drugs will surge the market growth during the study period.

#63. Cardiology news - Medical Technology Business Europe

A new generation of coronary artery stent that combines a biodegradable component ... New technique tests heart drugs on live beating heart tissue samples

#64. Carotid Stenting Systems Market Scope and Opportunities 2028

by Material of Construction (Bare Metal Stents, Polymers, Others); Specialty (Bio Absorbable and Biodegradable Stent, Drug Eluting Stent, ...

#65. Car Digital Cockpit Market Size |Incredible Possibilities and ...

"The latest study of the Sinus Bradycardia Drugs Market Statistics 2022 Report provides an elaborative analysis of the market size, industry ...